Excellence in

HEOR and Market Access

Patient-Reported Outcomes to Support the Adoption of Innovation

We believe that the best available therapies should be accessible to those who need it. That's why at PeriPharm, with the scientific rigor of academia, we are dedicated to facilitating market access to our clients' innovative solutions.

Who We Are

Founded in 2003, PeriPharm is a Canadian company specializing in pharmacoeconomics and outcomes research. Our mission is to offer high-quality and diversified services to ensure optimal market access. Our dedicated team works closely with our clients to provide services covering all their needs.

Our Expertise

As a leader in the field of pharmacoeconomics and outcomes research, PeriPharm has contributed to the success of several market access initiatives. We are distinguished through our:

  • In-depth knowledge of the Canadian health care system and payers’ requirements.
  • Established expertise in pharmacoeconomics and outcomes research for over 20 years.
  • Rigorous work methods arising from academia to produce high quality projects.
  • Commitment to our projects and flexibility of our services.
Learn more

Our Services

Submissions To Payers

We take care of all of our clients’ submissions to INESSS, CDR or private payers.

Health Economics

We specialize in economic model development and budget impact analysis

Real-World Evidence

We conduct a wide range of studies in a real-world practice setting that meet our clients’ research needs.

Evidence Synthesis

We are experienced in estimating the relative efficacy or safety of different treatments.

Strategic Consulting

We help our clients build a successful market access strategy, from the acquisition of licenses to the critical analysis of our clients’ submissions to payers.

Training in Health Economics

We offer training programs that can meet our clients’ specific needs.

Our Research Professionals

Our team is comprised of a diverse group of professionals, the majority of which have completed graduate studies in pharmacoeconomics, pharmacoepidemiology / biostatistics and drug development. Our team of dynamic professionals are entirely dedicated to the satisfaction of our clients and, through optimal synergistic collaboration, each contribute to the success of the company.

Learn more

Jean Lachaine, Ph.D.


As a recognized expert in health economics and outcomes research, Jean has accrued over 30 years of experience within the field. Trained as a pharmacist, Jean went on to complete doctoral studies in pharmacoeconomics and founded PeriPharm in 2003. In addition to his active involvement within PeriPharm, Jean also maintains his positions as a professor within the Faculty of Pharmacy and as an associate researcher within the Faculty of Medicine at the Université de Montréal. As a leader in the field, Jean participates on several advisory committees for major pharmaceutical companies and has acted as a pharmacoeconomics expert on the INESSS scientific committee for more than 10 years. His extensive knowledge of the field combined with his notable expertise represents an undeniable and valuable contribution to each and every project.

Catherine Beauchemin, Ph.D.


After completing a doctoral degree in pharmacoeconomics that was accompanied by several scholarships and honorary mentions, Catherine joined Jean as a partner of PeriPharm in April 2017 after more than 10 years of experience within the company. In addition to teaching pharmacoeconomics and health economics at various institutions, Catherine is also an associate professor at the Université de Montréal where she supervises several graduate students. Recognized for her leadership, analytical skills and team spirit, Catherine is fully committed to managing Peripharm and fulfilling the various mandates entrusted to her, which is essential for the success of the projects.

Our Partners and Collaborators

In order to meet all our clients’ needs and provide a turnkey service, we work closely with companies offering complementary services to ours. We have also developed a vast network of external experts including key opinion leaders working in various therapeutic fields with whom we regularly collaborate in the realization of our projects.